Skip to main content

Table 2 Comparison of the susceptibilities of ESBL-producing Escherichia coli strains to various antimicrobial agents

From: In vitro susceptibility of Escherichia colistrains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004–2012)

Antibiotic

ESBL-positive (n = 528)

ESBL-negative (n = 380)

p

 

S (%)

MIC90(mg/L)

S (%)

MIC90(mg/L)

 

FOS

93.8

2

98.4

1

0.001

TZP

95.3

16

95.8

8

0.707

IMP

100

0.25

99.2

0.25

0.073

AMK

92.8

8

95.8

4

0.061

NIT

86.2

64

85.8

64

0.869

LVX

17.2

32

46.8

32

< 0.001

  1. aDrug abbreviations: FOS, fosfomycin trometamol; TZP, piperacillin-tazobactam; IMP, imipenem; AMK, amikacin; NIT, nitrofurantoin; LVX, levofloxacin; ESBL, extended-spectrum beta-lactamase.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us